GLYCIPHAGE G 2MG TABLET 10'S

Glyciphage G 2mg Tablet is primarily used to treat type 2 diabetes mellitus, especially in people whose blood sugar levels are not controlled by diet and exercise alone. It helps to lower blood sugar levels.

Glyciphage G 2mg Tablet works by improving the body's sensitivity to insulin and decreasing the amount of glucose produced by the liver. It also helps in delaying the absorption of glucose from the intestines.

Common side effects may include nausea, vomiting, diarrhea, stomach pain, and loss of appetite. These side effects are usually mild and temporary.

It is generally not recommended to take Glyciphage G 2mg Tablet if you have kidney problems, as it can worsen the condition. Consult your doctor for advice.

If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.

It's important to consult your doctor before using Glyciphage G 2mg Tablet during pregnancy. Insulin is usually preferred for managing blood sugar during pregnancy.

Glyciphage G 2mg Tablet can interact with other medications. Inform your doctor about all the medications you are taking, including over-the-counter drugs, herbal supplements, and vitamins.

Avoid excessive alcohol consumption as it can increase the risk of side effects such as lactic acidosis. Also, maintain a healthy diet and exercise regularly.

Store Glyciphage G 2mg Tablet at room temperature, away from moisture and direct sunlight. Keep it out of reach of children.

Glyciphage G 2mg Tablet can cause hypoglycemia, especially when taken with other diabetes medications or insulin. It's important to monitor your blood sugar levels regularly.

Glyciphage G 2mg Tablet is a brand name for a medication containing metformin. The main difference between different metformin tablets often lies in the brand, the specific formulation (immediate release vs. extended release), and the manufacturer.

Glyciphage G 2mg Tablet may lead to modest weight loss in some individuals, but it is not primarily a weight loss medication. It mainly helps in controlling blood sugar levels.

Symptoms of lactic acidosis include nausea, vomiting, abdominal pain, muscle cramps, severe tiredness, and difficulty breathing. Seek immediate medical attention if you experience these symptoms.

Glyciphage G 2mg Tablet starts working within a few days to weeks. However, it may take several weeks to see the full effect on blood sugar levels. Consistency in taking the medication as prescribed is important.

Glyciphage G 2mg Tablet is generally safe for long-term use when taken as prescribed and monitored by a healthcare professional. Regular check-ups are necessary to monitor kidney function and vitamin B12 levels.

Glyciphage G2 is used to manage blood sugar levels in adults with type 2 diabetes mellitus. It is prescribed when diet, exercise, and single-drug therapy are not sufficient to control blood glucose. By combining metformin and glimepiride, it helps reduce high blood sugar and lowers the risk of diabetes-related complications such as nerve damage, kidney damage, eye problems, and cardiovascular disease when used as part of a comprehensive treatment plan.

Glyciphage G2 contains metformin and glimepiride, which work through complementary mechanisms. Metformin decreases glucose production in the liver, reduces absorption of glucose from the intestines, and improves the body’s response to insulin. Glimepiride stimulates the pancreatic beta cells to release more insulin. Together, these actions help lower fasting and post-meal blood sugar levels and improve overall glycemic control in type 2 diabetes.

Glyciphage G2 should be used with great caution in patients with liver disease. Metformin can increase the risk of lactic acidosis in people with significant hepatic impairment, and glimepiride metabolism may also be affected. In moderate to severe liver dysfunction, this combination is often avoided. Patients with any history of liver disease, hepatitis, cirrhosis, or unexplained jaundice must inform their doctor before starting Glyciphage G2. Liver function tests may be required before and during treatment, and any symptoms such as yellowing of the skin or eyes, dark urine, or persistent fatigue should be reported immediately.

Use of Glyciphage G2 in patients with kidney disease requires careful medical assessment. Metformin is eliminated mainly through the kidneys, and reduced kidney function increases the risk of lactic acidosis, a rare but serious side effect. In moderate to severe renal impairment, metformin-containing products are usually contraindicated or require strict dose adjustment and close monitoring. Patients with any history of kidney problems, reduced urine output, or those on nephrotoxic medicines should inform their doctor. Kidney function tests, such as serum creatinine and estimated glomerular filtration rate, are typically checked before starting and periodically during therapy.

The use of Glyciphage G2 during pregnancy is generally not preferred unless specifically recommended by a specialist. Glimepiride, a sulfonylurea, can cross the placenta and may cause low blood sugar in the newborn. For pregnant women with diabetes, insulin is usually the treatment of choice, as it has a more established safety profile. If you are planning a pregnancy, suspect you are pregnant, or become pregnant while taking Glyciphage G2, you should contact your doctor promptly. Your treatment plan may need to be changed to ensure optimal blood sugar control and safety for both mother and baby.

Glyciphage G2 is generally not recommended during breastfeeding without specific medical advice. Metformin can pass into breast milk in small amounts, and glimepiride may also be excreted, potentially causing low blood sugar in the nursing infant. If treatment for diabetes is required while breastfeeding, your doctor will weigh the benefits and risks and may suggest alternative therapies, such as insulin or metformin alone, depending on your clinical situation. Do not breastfeed while taking Glyciphage G2 unless your healthcare provider has clearly advised it and is monitoring both you and your baby.

Glyciphage G2 can sometimes cause low blood sugar, especially if meals are skipped, physical activity is increased unexpectedly, or other antidiabetic medicines are used concurrently. Hypoglycemia may lead to symptoms such as dizziness, blurred vision, confusion, or difficulty concentrating, which can impair your ability to drive or operate machinery safely. Until you know how Glyciphage G2 affects you, use caution when driving or performing tasks that require alertness. If you experience symptoms of low blood sugar, avoid driving and treat the hypoglycemia promptly according to your doctor’s advice.

Alcohol consumption should be limited or avoided while taking Glyciphage G2. Alcohol can increase the risk of hypoglycemia when combined with glimepiride and can also enhance the risk of lactic acidosis associated with metformin, particularly in people with liver or kidney problems, dehydration, or poor nutritional status. Binge drinking or regular heavy alcohol use is especially dangerous. If you choose to drink, discuss it with your doctor, keep intake minimal, avoid drinking on an empty stomach, and monitor your blood sugar closely.

If you have a known allergy to metformin, glimepiride, other sulfonylureas, sulfonamides, or any of the excipients in Glyciphage G2, you should not take this medicine. Signs of an allergic reaction may include rash, itching, swelling of the face, lips, tongue, or throat, severe dizziness, or difficulty breathing. Inform your doctor about any previous drug allergies or severe skin reactions before starting therapy. If you develop any of these symptoms after taking Glyciphage G2, stop the medicine and seek immediate medical attention.

Common side effects of Glyciphage G2 include nausea, vomiting, abdominal discomfort, diarrhea, loss of appetite, headache, and dizziness. Hypoglycemia is also a frequent concern, especially if meals are missed or delayed. Mild gastrointestinal symptoms often improve as the body adjusts to the medicine. However, you should seek medical help immediately if you experience signs of severe hypoglycemia such as confusion, seizures, or loss of consciousness, or symptoms suggestive of lactic acidosis, including rapid breathing, severe weakness, muscle pain, unusual sleepiness, or persistent abdominal pain. Yellowing of the skin or eyes, dark urine, or swelling of the legs should also be reported promptly, as they may indicate liver or kidney problems or other serious conditions.